Nadia Patel’s Insights

333 total results. Page 1 of 28.

Investigations Blog
Subscription Based Telehealth Companies Indicted in Alleged $100 Million Prescription Drug Distribution Scheme
Investigations Blog
Rare Rebuke: Federal Courts Significantly Limit DOJ Subpoenas to Gender Affirming Care Providers
Investigations Blog
Eleventh Circuit Actively Engaged on Question of FCA’s Qui Tam Provisions’ Constitutionality
Investigations Blog
DOJ Once Again to Corporate Community: White Collar Criminal Enforcement Not Slowing Down
Investigations Blog
CVS to Pay $37.8 Million to Settle Overbilling Claims
Investigations Blog
Zafirov One Year Later: Constitutional Challenges to the False Claims Act’s Qui Tam Provision
Investigations Blog
Medtronic FCA Claims Survive Reconsideration Despite First Circuit’s But-For Causation Standard
Customs & Import Compliance Blog
As the (Customs and Trade) World Turns: November 2025
Investigations Blog
Jury Finds Global Health Care Company Novo Nordisk Not Liable in Whistleblower’s FCA Suit
Investigations Blog
Fifth Circuit Judge Questions Constitutionality of the FCA’s Qui Tam Provision
Investigations Blog
Brothers Convicted in $100 Million HIV Drug Fraud Scheme
Investigations Blog
Private Equity Firm Not Liable for Alleged FCA Retaliation Claims by Former Employee of Portfolio Company